Path Therapeutics Inc's therapeutic assets and associated patent(s) will now exist within Stream Neuroscience Inc.
Learn more about Stream Neuroscience by visiting our LinkedIn page or www.streamneurosci.com
Path Therapeutics' proprietary phenotypic-screening technology is uncovering new therapeutics and novel druggable targets for diseases of the central nervous system, including rare and devastating genetic forms of childhood epilepsy.
Company Details
- Employees
- 1
- Founded
- -
- Address
- Calgary, Alberta T2n1n4, Ca
- Phone
- 403.992.3461
- ku****@****bio.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pathbio.com
- HQ
- Calgary, Alberta
Path Therapeutics, Inc. Questions
Path Therapeutics, Inc.'s helpline number is 403.992.3461
Path Therapeutics, Inc.'s website is pathbio.com
Path Therapeutics, Inc.'s LinkedIn profile is https://ca.linkedin.com/company/pathbio
Path Therapeutics, Inc. has
1 employees.
View email and phone details for 1
employees at Path Therapeutics, Inc..
Path Therapeutics, Inc.'s industry is
Biotechnology Research
Path Therapeutics, Inc.'s top competitors are
Fittogo.ca,
Guavy Inc.,
Build Resilience International Institute,
Serna Bio,
Virogen Biotechnology,
Stream Neuroscience,
Lumiio Inc.,
Aurteen,
Inuka By Sue Leonard,
Epilepsy Association Of Calgary.
Path Therapeutics, Inc.'s support email address is kurrasch@pathbio.com
Path Therapeutics, Inc.'s categories are Biotechnology Research
Path Therapeutics, Inc.'s founding year is 2014
